Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-055362

EVP and General Counsel sold 7,336 shares at $100.65 ($738,368)

  • EVP and General Counsel acquired 7,336 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Parschauer Karah Herdman · EVP and General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-08 Exercise or conversion : show line 1 in the form +7,336 $54.50 $399,812 36,004 D
2021-09-08 Sale : show line 2 in the form −7,336 $100.65 $738,368 28,668 D
Open-market sales · 7,336 sh · avg $100.65 · $738,368

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-08 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −7,336 17,664 D
Loading xslF345X03/doc4.xml…